Evidence map›Paper›PMID 42499541›Full record

ArticleFrontiers in cellular and infection microbiology2026

Javier Asensio-López, Beatriz Rapún-Araiz, Begoña Euba, Asier Domínguez-San Pedro, Álvaro Sanmartín, Celia Gil-Campillo, David San León, Pablo Chacón, Goizeder Almagro, Ana Ardá and 4 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Javier Asensio-LópezInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Beatriz Rapún-AraizInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Begoña EubaInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Asier Domínguez-San PedroInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Álvaro SanmartínLaboratory of Microbial Pathogenesis, Navarrabiomed-Universidad Pública de Navarra (UPNA)-Complejo Hospitalario de Navarra (CHN), IdiSNA, Pamplona, Navarra, Spain.
Celia Gil-CampilloInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
David San LeónDepartment of Systems Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
Pablo ChacónDepartment of Biological Physical Chemistry, Blas Cabrera Institute of Physical Chemistry, CSIC, Madrid, Spain.
Goizeder AlmagroInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Ana ArdáCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
Saioa BurguiAsociación de la Industria Navarra (AIN)-Gobierno de Navarra, Cordovilla, Spain.
Iñigo LasaLaboratory of Microbial Pathogenesis, Navarrabiomed-Universidad Pública de Navarra (UPNA)-Complejo Hospitalario de Navarra (CHN), IdiSNA, Pamplona, Navarra, Spain.
Alejandro Toledo-AranaInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.
Junkal GarmendiaInstituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas (IdAB-CSIC)-Gobierno de Navarra, Mutilva, Navarra, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tryptophan plays a key role in regulating human lung homeostasis and immunity through the indoleamine 2,3-dioxygenase (IDO) and aryl hydrocarbon receptor (AhR) signalling pathways. In patients with chronic obstructive pulmonary disease (COPD), altered IDO and AhR activity is observed, potentially favouring infection by pathogens capable of synthesizing their own tryptophan. In this study, we investigated the contribution of tryptophan availability to lung infection by Methods: A chemically defined medium with controlled tryptophan levels was developed, and used to determine bacterial (i) metabolite consumption/excretion; (ii) genome-wide differential gene expression and post-transcriptional regulation; (iii) Results: Under tryptophan-rich conditions, we observed up-regulation of Conclusions: These findings demonstrate that

Indexed as

Haemophilus InfectionsHaemophilus influenzaeTryptophanAnimalsDisease Models, AnimalGene Expression ProfilingGene Expression Regulation, BacterialHumansLungMiceTryptophanairway infectionHaemophilus influenzaeimmune modulationmetabolic drug targetmtr-sdaCA excludonpost-transcriptional regulation of gene expressiontryptophan biosynthesis

Identifiers

PMID42499541
PMCPMC13395689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.